Cost-effectiveness analysis of Avance < sup > ® < /sup > allograft for the treatment of peripheral nerve injuries in the USA

Conclusion: The use of allograft with the Avance Nerve Graft has the potential to be a cost-effective alternative to autograft for the surgical treatment of PNI in the USA.PMID:38031842 | DOI:10.57264/cer-2023-0113

Source: Journal of Comparative Effectiveness Research - November 30, 2023 Category: General Medicine Authors: Amir Ansaripour Ann Thompson Joseph F Styron Mehdi Javanbakht Source Type: research